The federal government needs to make it an urgent priority to provide increased and predictable funding for health and biosciences research, or risk losing the nation’s health research workforce to competing countries like the U.S., the U.K. and Australia, says Paul-Émile Cloutier, president and CEO of HealthCareCAN, in an op-ed.
Topic: COVID-19 pandemic
Canada needs to address inequities in who has access to the power and promise of data science and advanced analytics, including by supporting training for grassroots, charitable and community organizations to collect, access and manage data, Kelly Nolan, an external affairs and equity, diversity and inclusion expert based in Ottawa, says in an op-ed.
The disruption caused by the COVID-19 pandemic has created the perfect conditions to consider new, innovative approaches to rapidly upskill and redeploy domestic talent, say AJ Tibando and Arvind Gupta, the executive director and the CEO of Palette Skills, respectively, in an opinion piece.
Research Money spoke to Jean-Eric Paquet, the director general of the European Commission’s Research and Innovation directorate, along with Roseann O’Reilly Runte, the president and CEO of the Canada Foundation for Innovation, on how COVID-19 will affect research infrastructure and how those lessons might apply to future crises.
Canadians needs to “embrace the entrepreneur” and invest in the innovation ecosystem to make Canada a leader in the digital economy, says Perry Kinkaide, a former public servant, corporate executive and manager of Kinkaide Enterprises Inc., in an opinion piece.
The Canadian Institutes of Health Research (CIHR) will be supporting the creation of a new Centre for Pandemic Preparedness and Health Emergencies, CIHR president Michael J. Strong says in an op-ed.
Building a circular economy for plastics in Canada will take smart solutions, says Christina Seidel, executive director of the Recycling Council of Alberta and co-chair of the Plastics Alliance of Alberta, in an op-ed. These include locally driven initiatives, collaboration across sectors and organizations, research investment and innovation to eliminate unnecessary plastics and reduce plastic waste.
Providence Therapeutics, a Calgary biotechnology company in human trials with its COVID-19 vaccine, struck a supply deal with the Government of Manitoba after sending the federal government a proposal and receiving no response. In a video, Providence founder and CEO Brad Sorenson criticized Ottawa’s “apathetic response” as “unacceptable” and he implored the government to take initiative to establish a secure domestic vaccine supply.
Prime Minister Justin Trudeau is much more focused on his government’s response to COVID-19 than on science and innovation priorities, judging by the PM’s updated mandate letter to the minister of innovation. The letter mentions the world “innovation” once, compared with more than a half-dozen references to COVID-19 and the federal response to the pandemic
The federal government needs to support an inclusive engineering biology ecosystem that leverages Canadian-grown capacities across industry, academia and government, Bettina Hamelin, president and CEO of Ontario Genomics, says in an editorial. Canada needs a comprehensive and aligned roadmap for a public-private partnership and investment strategy to benefit from the increasing opportunities in this emerging sector, she says.